Literature DB >> 12096090

Re: Blocking oncogenic Ras signaling for cancer therapy.

Silvana Canevari, Silvia Biocca, Mariangela Figini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12096090     DOI： 10.1093/jnci/94.13.1031

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Effect of DNA Glycosylases OGG1 and Neil1 on Oxidized G-Rich Motif in the KRAS Promoter.

Authors:  Annalisa Ferino; Luigi E Xodo
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

2.  Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.

Authors:  Tomoyuki Tanaka; Roger L Williams; Terence H Rabbitts
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

3.  Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins.

Authors:  Susanna Cogoi; Manikandan Paramasivam; Barbara Spolaore; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2008-05-19       Impact factor: 16.971

Review 4.  Epigenetic changes in fibroblasts drive cancer metabolism and differentiation.

Authors:  Rajeev Mishra; Subhash Haldar; Surabhi Suchanti; Neil A Bhowmick
Journal:  Endocr Relat Cancer       Date:  2019-12       Impact factor: 5.678

5.  An enzymatic on/off switch-mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA.

Authors:  Qing-Lin Wang; Cui-Lan Zhou; Yu-Fang Yin; Li Xiao; Yuan Wang; Kai Li
Journal:  J Clin Lab Anal       Date:  2020-03-24       Impact factor: 2.352
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.